Egypt bans four active ingredients
This article was originally published in SRA
Executive Summary
The Egyptian Ministry of Health and Population’s High Technical Committee has taken action on four drugs – vincamine, vinpocetine, nitrofurazone and ramelteon – due to concerns about their safety, among other reasons.